Over the past 12 months, 5 insiders at Spyre Therapeutics, Inc. filed 29 open-market SEC Form 4 transactions on SYRE: 0 purchases worth $0 and 29 sales worth $410.6M. Insiders have been net sellers over this period. The most recent filing was on Jul 1, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 1, 26 | Scott L BurrowsChief Financial Officer | SELL | 5.8K | $88.37 | $506K |
| Jul 1, 26 | Sheldon SloanChief Medical Officer | SELL | 6.5K | $88.34 | $569K |
| Jul 1, 26 | Cameron TurtleChief Executive Officer | SELL | 10.2K | $88.91 | $890K |
| Jun 25, 26 | Scott L BurrowsChief Financial Officer | SELL | 10.0K | $87.14 | $871K |
| Jun 23, 26 | Fairmount Funds Management Llc | SELL | 4.68M | $85.31 | $399.7M |
| Jun 22, 26 | Michael Thomas Henderson | SELL | 20.0K | $100.00 | $2.0M |
| Jun 1, 26 | Scott L BurrowsChief Financial Officer | SELL | 3.1K | $72.06 | $223K |
| May 1, 26 | Scott L BurrowsChief Financial Officer | SELL | 12.5K | $71.37 | $892K |
| Mar 3, 26 | Scott L BurrowsChief Financial Officer | SELL | 2.3K | $41.66 | $93K |
| Mar 2, 26 | Cameron TurtleChief Executive Officer | SELL | 9.1K | $42.49 | $387K |
| Feb 2, 26 | Cameron TurtleChief Executive Officer | SELL | 14.0K | $32.87 | $462K |
| Jan 2, 26 | Cameron TurtleChief Executive Officer | SELL | 12.7K | $32.39 | $387K |
| Dec 1, 25 | Cameron TurtleChief Executive Officer | SELL | 11.0K | $29.83 | $316K |
| Nov 3, 25 | Cameron TurtleChief Executive Officer | SELL | 28.2K | $23.66 | $651K |
| Sep 2, 25 | Scott L BurrowsChief Financial Officer | SELL | 18.4K | $16.26 | $300K |
| Nov 6, 24 | Jeffrey W. AlbersDirector | SELL | 6.7K | $36.76 | $246K |
| Oct 25, 24 | Jeffrey W. AlbersDirector | SELL | 300 | $36.43 | $11K |
| Sep 3, 24 | Scott L BurrowsChief Financial Officer | SELL | 18.5K | $28.17 | $522K |
Over the past 12 months, insiders at Spyre Therapeutics, Inc. filed 0 open-market purchases worth $0 and 29 sales worth $410.6M on SYRE, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 1, 26.
5 different insiders at Spyre Therapeutics, Inc. filed open-market SEC Form 4 transactions on SYRE over the last 12 months.
InsiderTape plots every SYRE insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Spyre Therapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →